Back | Next |
home / stock / nvs / nvs message board
Subject | By | Source | When |
---|---|---|---|
Ok thank you | Maddog 112 | investorshub | 03/23/2020 11:03:30 AM |
It won't have any effect at all on | DewDiligence | investorshub | 03/23/2020 2:26:35 AM |
How much will this affect the stock price | Maddog 112 | investorshub | 03/23/2020 2:13:54 AM |
Yesthat was announced on Friday: #msg-154462215. | DewDiligence | investorshub | 03/23/2020 2:09:51 AM |
Is it true $NVS to supply 160 mil | Maddog 112 | investorshub | 03/23/2020 1:43:52 AM |
More on the same story (Beovu safety): | DewDiligence | investorshub | 02/25/2020 4:04:06 PM |
Acceptance of a BLA/NDA application for review doesnt | DewDiligence | investorshub | 02/25/2020 12:17:30 PM |
And so this got ignored. :-( | Ecomike | investorshub | 02/25/2020 2:32:15 AM |
The cause is a safety update re Beovu | DewDiligence | investorshub | 02/24/2020 7:40:46 PM |
5.5% drop on a biotech drug firm like | Ecomike | investorshub | 02/24/2020 7:35:21 PM |
$NVS 12/5/19 R&D Day slides: | DewDiligence | investorshub | 12/08/2019 11:53:17 PM |
$NVS PR in conjunction with R&D Day investor webcast: | DewDiligence | investorshub | 12/06/2019 12:37:24 AM |
These shares are a BUY - Up and | elotto777 | investorshub | 11/26/2019 5:02:02 PM |
NVS acquires$ MDCO for $85/sh casha 64% premium | DewDiligence | investorshub | 11/24/2019 8:47:35 PM |
CHMP approves $NVS Mayzent for SPMS: | DewDiligence | investorshub | 11/15/2019 2:57:19 PM |
News: $NVS ROSEN, A LEADING GLOBAL LAW FIRM, | whytestocks | investorshub | 11/10/2019 1:45:26 AM |
FDA approves$ NVS Beovu(a/k/a brolucizumab/RTH258) for wet $AMD3mo | DewDiligence | investorshub | 10/08/2019 2:18:25 PM |
Govind: The latest Market analysis report on | Govind | investorshangout | 09/04/2019 9:30:41 AM |
Here's the cause of today's sell-off: | DewDiligence | investorshub | 08/06/2019 7:10:04 PM |
Any clue what too the air out this | Ecomike | investorshub | 08/06/2019 7:04:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Novartis AG Company Name:
NVS Stock Symbol:
NYSE Market:
– Continued enrollment globally in multiple clinical studies of vepdegestrant in ER+/HER2- metastatic breast cancer, including the VERITAC-2 Phase 3 trial in the second-line setting and the study lead-in for the VERITAC-3 Phase 3 trial in the first-line setting – – ...
2024-05-05 14:25:00 ET There are many reasons to invest in excellent dividend stocks. Such investments are often worth the trouble regardless of whether you're investing for the dividend, or for making capital gains from the robust business (always a laudable goal). But here's the common th...
The Federal Trade Commission (FTC) is intensifying its efforts to challenge numerous pharmaceutical patent listings, aiming to facilitate...